TY  - RPRT
TI  - Two therapeutic CRISPR/Cas9 gene editing approaches revert FTD/ALS cellular pathology caused by a C9orf72 repeat expansion mutation in patient derived cells
AU  - Sckaff, M.
AU  - Gill, K.
AU  - Sachdev, A.
AU  - Birk, A. M.
AU  - Aladesuyi Arogundade, O.
AU  - Watry, H. L.
AU  - Keough, K. C.
AU  - Tsai, Y.-C.
AU  - Ziegle, J.
AU  - Conklin, B. R.
AU  - Clelland, C. D.
PY  - 2022
DO  - 10.1101/2022.05.21.492887
UR  - https://www.biorxiv.org/content/10.1101/2022.05.21.492887v1
ID  - 10.1101/2022.05.21.492887
ER  -